The Impact of the Assad Regime's Fall on the Captagon Trade
The recent report by French magazine "Le Point" raises critical questions about the future of the Captagon drug trade in Syria following the fall of the Assad regime. The article highlights the extensive network of Captagon production facilities that were uncovered, suggesting that the Assad family was deeply involved in the smuggling of this synthetic drug. The report indicates that the regime's collapse has exposed the vulnerabilities of a drug state that has thrived on the production and export of Captagon, which is a stimulant known scientifically as phenethylline.
Captagon's Economic Significance
The Captagon trade has proven to be a significant economic driver for the Syrian regime, with sales soaring from an estimated $3.46 billion in 2020 to $5.7 billion in 2021. The drug, which is often sold in pill form for prices ranging from $3 to $25 depending on the market, has been linked to severe health issues, including cardiovascular problems and psychological disorders. The magazine notes that the production has shifted from smaller operations in rebel-held areas to large-scale industrial operations in regions loyal to Assad, contradicting the regime's narrative that blamed opposition groups for the drug's proliferation.
Future Prospects for Captagon Production
As the new authority in Syria emerges, there are indications that efforts may be made to dismantle the Captagon production network. However, the magazine warns that the legacy of the drug state may persist unless significant changes are implemented. Observers note that officials from the Fourth Division of the Syrian military, led by Maher al-Assad, have been implicated in the ongoing smuggling operations, utilizing state-owned ports for distribution. Journalist Nassim Nasr suggests that the new leadership's commitment to curbing Captagon smuggling will be crucial for establishing legitimacy and rebuilding the country.
